Science Life is a guide to the changing world of biomedicine, as seen from our home at the University of Chicago Medicine. We’re interested in clinical and theoretical advances – from new kinds of cancer treatments to new ideas about how life evolved. Patients can visit this blog to ask questions or offer their own insights into diseases and therapies. Doctors and scholars can trade ideas about the latest studies or controversies. And anyone curious about the life sciences can join us in figuring out what this fascinating field means for our everyday lives.
ScienceLife's Latest Posts
New method analyzes whole-genome gene expression to predict whether tumors respond to chemotherapy
It took 29 years, but the FDA finally approved a drug developed at UChicago to provide relief for patients taking powerful pain relievers.
The drug, developed with the help of Yusuke Nakamura and his lab, inhibits the action of a protein that is overproduced by several tumor types, including lung and breast.
Social media is a huge potential source of data for medical researchers, but UChicago's Jeanne Farnan says questions of consent and user intent raise plenty of ethical concerns.
A new study shows that a protein known to inhibit the growth of liver and colon cancers can promote the development of skin cancers as well.
Log in to leave a comment